跳至主要内容
临床试验/ISRCTN11665378
ISRCTN11665378进行中(未招募)未知

The utility of frequency-modulated electromagnetic neural stimulation as a third-line treatment in patients with painful diabetes-related peripheral neuropathy: a randomised controlled trial

niversity of Birmingham0 个研究点目标入组 356 人开始时间: 2023年1月16日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
356

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged =18 years
  • 2. Neuropathic pain affecting both feet for =3 months or taking pain medication for neuropathic pain for =3 months
  • 3. Mean pain score =4 on the daily NRS for 1 week prior to randomisation
  • 4. Douleur Neuropathique 4 (DN-4) questionnaire score =4/10 at screening to confirm the diagnosis of bilateral distal symmetrical neuropathic pain
  • 5. Diabetes-related neuropathy based on the Michigan Neuropathy Screening Instrument (MNSI) (MNSI questionnaire scored =7 or examination scored >2)
  • 6. HbA1c <108 mmol/mol or 12% (within the last 2 months)
  • 7. Have tried at least two drugs from two different classes for PDPN
  • 8. Willing and able to comply with the study schedule and be available for the treatment duration
  • 9. Able to give written informed consent

排除标准

  • 1. Non-diabetic neuropathies
  • 2. Currently using TENS for PDPN
  • 3. History of epilepsy
  • 4. Other painful medical conditions where the pain is significantly more severe than their PDPN pain (patients will not be excluded if the pain is transient in nature)
  • 5. Major amputations of the lower limbs
  • 6. Active diabetic foot ulcers
  • 7. Diagnosed malignancy
  • 8. Pacemakers, defibrillator or neurostimulator
  • 9. Pregnancy

研究者

相似试验